ClinicalTrials.gg
RecruitingNCT07689747Updated Nov 3, 2026

Neurocognitive Enrichment During Functional Performance Testing in Chronic Ankle Instability

An interventional study of Standard Testing Condition and Internal Focus of Attention in Chronic Ankle Instability, CAI, sponsored by Bahçeşehir University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 16 Years to 25 Years. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by Bahçeşehir University · Not applicable, Interventional, and Screening

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.
Updated Nov 3, 2026Primary completion movedStudy completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
16 Years to 25 Years
Sex
All
01

Study summary

Chronic ankle instability (CAI) is associated with recurrent ankle sprains, impaired postural control, and reduced functional performance. Traditional functional performance tests are commonly used to assess athletes with CAI; however, these assessments are typically conducted under isolated motor conditions and may not adequately reflect the neurocognitive demands encountered during sports participation.

The aim of this randomized crossover study is to investigate the acute effects of neurocognitively enriched testing conditions on balance and functional performance in athletes with CAI. Participants will perform functional performance tests under four different conditions: standard testing, internal focus of attention, external focus of attention, and cognitive dual-task conditions. Dynamic balance, vertical jump performance, single-leg hop performance, figure-of-8 hop performance, and dual-task cost will be assessed and compared across conditions.

The findings of this study may contribute to the development of more ecologically valid assessment approaches for athletes with CAI and provide insights into the influence of attentional focus and cognitive load on functional performance.

Read the detailed description

Chronic ankle instability (CAI) is a common consequence of lateral ankle sprains and is characterized by recurrent episodes of giving way, repeated sprains, impaired sensorimotor control, and persistent functional limitations. Although functional performance tests are widely used to assess readiness for sports participation and return-to-sport status, these assessments are typically performed under isolated motor conditions and may not adequately represent the complex neurocognitive demands encountered during athletic activities.

Recent evidence from motor learning and sports medicine literature suggests that attentional focus strategies and cognitive loading can substantially influence movement performance, postural control, and motor execution. Internal focus of attention directs individuals toward body movements and joint positions, whereas external focus of attention emphasizes movement outcomes and environmental effects. In addition, dual-task paradigms introduce cognitive demands that may alter motor performance by increasing attentional load and competing for cognitive resources. Understanding how these neurocognitive factors influence functional performance may provide valuable information for the assessment and management of athletes with CAI.

The present study aims to examine the acute effects of neurocognitively enriched testing conditions on balance and functional performance in athletes with CAI. By comparing performance under standard testing, internal focus, external focus, and cognitive dual-task conditions, the study seeks to determine whether commonly used functional performance tests are sensitive to variations in attentional focus and cognitive load.

This investigation is expected to contribute to a better understanding of the interaction between cognitive processes and motor performance in athletes with CAI. The findings may support the development of more ecologically valid assessment strategies and provide clinically relevant information for rehabilitation planning, functional evaluation, and return-to-sport decision-making in athletic populations with chronic ankle instability.

02

Conditions studied

  • Chronic Ankle Instability, CAI

Keywords

  • Chronic Ankle Instability (CAI)
  • Dynamic Balance
  • Attentional Focus
  • dual task
03

In context

Lead sponsor

Bahçeşehir University is the lead sponsor of 128 studies on the registry; 26 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged between 16 and 25 years.
  • Actively participating as a licensed football, basketball, or volleyball athlete.
  • History of at least one lateral ankle sprain occurring ≥12 months before study participation, associated with pain and/or swelling and resulting in at least one day of restricted physical activity.
  • History of recurrent ankle instability, defined as at least two episodes of giving way during the previous 6 months and/or recurrent ankle sprains.
  • Cumberland Ankle Instability Tool (CAIT) score ≤25.
  • Participating in regular sports training at least 3 times per week.
  • No ankle surgery within the previous 6 months.
  • Able to safely perform all functional performance tests.
  • Willing to undergo assessment of the more symptomatic ankle; in participants with bilateral chronic ankle instability, the ankle with the lower CAIT score will be evaluated.

Exclusion criteria

Exclusion Criteria:

  • Acute ankle sprain within the previous 6 weeks accompanied by significant pain, swelling, or functional limitation.
  • History of major lower-extremity surgery (e.g., knee, hip, or ankle surgery).
  • History of neurological, vestibular, or systemic disorders that may affect balance or motor performance.
  • Visual or cognitive impairments that could interfere with test performance.
  • Lower-extremity injuries other than ankle instability within the previous 6 months that may negatively affect functional performance.
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Standard Testing Condition

    Participants perform all functional performance tests under standard testing conditions without attentional focus instructions or additional cognitive tasks. This condition serves as the reference condition for comparison with neurocognitively enriched testing conditions.

    Behavioral: Standard Testing Condition

  • Experimental
    Internal Focus of Attention Condition

    Participants perform all functional performance tests while receiving internal focus of attention instructions directing attention toward body movements, joint positions, and movement control.

    Behavioral: Internal Focus of Attention

  • Experimental
    External Focus of Attention Condition

    Participants perform all functional performance tests while receiving external focus of attention instructions directing attention toward movement outcomes and environmental targets.

    Behavioral: External Focus of Attention

  • Experimental
    Cognitive Dual-Task Condition

    Participants perform all functional performance tests while simultaneously completing a cognitive task involving backward repetition of number sequences to increase cognitive load

    Behavioral: Cognitive Dual-Task Condition

Interventions

  • BehavioralStandard Testing Condition

    Participants perform functional performance tests under standard testing conditions without attentional focus instructions or additional cognitive tasks. This condition serves as the reference condition for comparison with neurocognitively enriched testing conditions

  • BehavioralInternal Focus of Attention

    Participants perform functional performance tests while receiving internal focus of attention instructions directing attention toward body movements, joint positions, and movement control during task execution.

  • BehavioralExternal Focus of Attention

    Participants perform functional performance tests while receiving external focus of attention instructions directing attention toward movement outcomes and environmental targets during task execution.

  • BehavioralCognitive Dual-Task Condition

    Participants perform functional performance tests while simultaneously completing a cognitive task involving backward repetition of number sequences, increasing cognitive load during motor performance.

06

What researchers measure

Primary outcomes

  1. Dynamic Balance Performance

    Dynamic balance performance assessed using the Y Balance Test under standard, internal focus of attention, external focus of attention, and cognitive dual-task conditions.

    Time frame: Day 1 (during the study assessment session)

Secondary outcomes

  1. Vertical Jump Performance

    Vertical jump height assessed using the My Jump 2 application under different neurocognitive testing conditions.

    Time frame: Day 1 (during the study assessment session)

  2. Figure-of-8 Hop Performance

    Figure-of-8 hop completion time assessed under different neurocognitive testing conditions.

    Time frame: Day 1 (during the study assessment session)

  3. Dual-Task Cost

    Dual-task cost calculated as the percentage change in motor performance between single-task and dual-task conditions.

    Time frame: Day 1 (during the study assessment session)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be made publicly available in order to maintain participant confidentiality and comply with institutional ethical requirements.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Jun 2026 (actual). Primary completion is estimated for Jan 2027, 7 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 3, 2026: primary completion Oct 2026 → Jan 2027 and completion Nov 2026 → Jan 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 13, 2026
First posted
Jul 8, 2026
StartActual
Jun 8, 2026
Primary completionEst.
Jan 2027was Oct 2026
CompletionEst.
Jan 2027was Nov 2026
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
1 site added, 1 site removed
Show site
  • Istanbul Nisantasi University · Istanbul, Turkey (Türkiye)
Show 1 removed
  • Istanbul Nisantasi University · Istanbul, Turkey (Türkiye)
Nov 3, 2026
Primary completion
Oct 8, 2026→Jan 2027
Nov 3, 2026
Study completion
Nov 8, 2026→Jan 2027
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    1 site added, 1 site removed
    Show site
    • Istanbul Nisantasi University · Istanbul, Turkey (Türkiye)
    Show 1 removed
    • Istanbul Nisantasi University · Istanbul, Turkey (Türkiye)
    Primary completion Oct 8, 2026→Jan 2027
    Study completion Nov 8, 2026→Jan 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07689747
Collaborators
The Scientific and Technological Research Council of Turkey
Responsible party
Büşra Tamgüç (Research assistant, Bahçeşehir University) — Principal investigator
First posted
Jul 8, 2026
Start date
Jun 8, 2026
Primary completion
Jan 2027 (estimated)
Completion
Jan 2027 (estimated)
Last update
Nov 3, 2026

Study contacts

Elif Aleyna Yazgan, Phd
Contact
elifaleyna.yazgan@nisantasi.edu.tr
000000000 ext. 000000000

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion